AOCI at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s AOCI?
- Sarepta Therapeutics, Inc. (SRPT) reported AOCI of -$121K in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s AOCI changed year-over-year?
- Sarepta Therapeutics, Inc.'s AOCI decreased by 455.9% year-over-year, from $34K to -$121K.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s AOCI?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s AOCI has grown at a 146.3% compound annual growth rate (CAGR), from $3K to $272K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.